FDA Issues Warning Letter to OSRX
May 14, 2025
May 14, 2025
WASHINGTON, May 14 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to OSRX Inc.:
* * *
To: OSRX, Inc., 1120 Kensington Ave, Missoula, MT 59801-5619, United States
Dear Ms. Frost:
You registered your facility with the U.S. Food and Drug Administration (FDA) as an outsourcing facility under section 503B of the Federal Food, Drug, and Cosmetic Act (FDCA) [21 U.S.C. Sec. 353b]/1 o . . .
* * *
To: OSRX, Inc., 1120 Kensington Ave, Missoula, MT 59801-5619, United States
Dear Ms. Frost:
You registered your facility with the U.S. Food and Drug Administration (FDA) as an outsourcing facility under section 503B of the Federal Food, Drug, and Cosmetic Act (FDCA) [21 U.S.C. Sec. 353b]/1 o . . .